OpenVSafe by OpenVAERS
Search V-safe

HX3-14088-76788

3 vaccinations 12 coded responses 30 check-ins 12 free-text entries 4 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
062 / CT
Registered
2021-01-11
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-21
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-11
    Registered in v-safe
  3. 2021-01-11
    Dose 2 — Pfizer-BioNTech
  4. 2021-01-11
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  5. 2021-01-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  6. 2021-01-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dysphonia, Respiratory tract congestion, Rhinorrhoea — Feeling: Poor · Site: Pain, Itching · Headache, Muscle or body aches, Fatigue or tiredness, Nausea
    Free text: runny nose congestion scratchy voice
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-01-14
    Survey response — days 1–6 daily, dose 2
    MedDRA: Respiratory tract congestion — Feeling: Good · Site: Pain, Redness · Headache, Muscle or body aches
    Free text: congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-15
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site mass — Feeling: Good · Site: Pain, Redness, Itching · Headache
    Free text: mild lump at shot site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Redness, Itching · None
    Adult check-in
  10. 2021-01-17
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site swelling — Feeling: Good · Site: Itching
    Free text: lump under skin at injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-18
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-01-25
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-02-01
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-02-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-15
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-02-22
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-04-12
    Survey response — 3 months, dose 2
    MedDRA: Arthralgia, Unevaluable event — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: horrible joint pain in all fingers. · Healthcare visit (other): x-ray
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-04-12
    Report sent to call center — 3 months, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  19. 2021-07-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-10-03
    Dose 3 — Pfizer-BioNTech
  21. 2021-10-03
    Health check-in — day 0, dose 3
    Feeling: Good · None
    Adult check-in
  22. 2021-10-04
    Survey response — days 1–6 daily, dose 3
    MedDRA: Chest discomfort, Dizziness — Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: dizzy. tight breathing.
    MedDRA releases: 2024-11 · check-in free text available
  23. 2021-10-05
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Redness, Swelling · Headache
    Adult check-in
  24. 2021-10-06
    Survey response — days 1–6 daily, dose 3
    MedDRA: Decreased appetite — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Nausea, Abdominal pain
    Free text: loss appetite
    MedDRA releases: 2024-11 · check-in free text available
  25. 2021-10-07
    Survey response — days 1–6 daily, dose 3
    MedDRA: Ageusia, Decreased appetite — Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Muscle or body aches, Fatigue or tiredness, Nausea
    Free text: loss of taste, loss of appetite
    MedDRA releases: 2024-11 · check-in free text available
  26. 2021-10-08
    Survey response — days 1–6 daily, dose 3
    MedDRA: Ageusia — Feeling: Good · Site: Pain, Swelling, Itching · Headache
    Free text: loss of taste
    MedDRA releases: 2024-11 · check-in free text available
  27. 2021-10-10
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  28. 2021-10-17
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  29. 2021-10-24
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  30. 2021-10-31
    Health check-in — day 28, dose 3
    Feeling: Fair
    Adult check-in
  31. 2021-11-07
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-11-14
    Survey response — day 42, dose 3
    MedDRA: Heart rate increased, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: increased pulse · Healthcare visit (other): holter monitor
    MedDRA releases: 2024-11 · check-in free text available
  33. 2021-11-14
    Report sent to call center — day 42, dose 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  34. 2021-11-15
  35. 2021-11-15
  36. 2022-01-02
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  37. 2022-04-03
    Survey response — 6 months, dose 3
    MedDRA: Arrhythmia, Supraventricular tachycardia — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: heart rythm/ SVT.
    MedDRA releases: 2024-11 · check-in free text available
  38. 2022-04-03
    Report sent to call center — 6 months, dose 3
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  39. 2022-04-05
  40. 2022-10-03
    Survey response — 12 months, dose 3
    MedDRA: Arthralgia, Blood cholesterol increased, Fatigue, Hepatic enzyme increased, Pain in extremity — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Elevated Liver enzymes, high cholesterol, severe arthritis like pain in hands, fatigue.
    MedDRA releases: 2024-11 · check-in free text available
  41. 2022-10-03
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  42. 2022-10-05
  43. 2022-10-05
  44. 2022-10-05
  45. 2022-10-05

Vaccinations

DoseDateManufacturerCo-administered
12020-12-21Pfizer-BioNTech
22021-01-11Pfizer-BioNTech
32021-10-03Pfizer-BioNTech No

Call center

4 call center cases

4 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-13

Systemic reaction (other): runny nose congestion scratchy voice

2021-01-14

Systemic reaction (other): congestion

Release 2 — days 1–6 daily, dose 2

2021-01-15

Systemic reaction (other): mild lump at shot site

2021-01-17

Systemic reaction (other): lump under skin at injection site

Release 7 — 3 months, dose 2

2021-04-12

Symptoms: horrible joint pain in all fingers.
Healthcare visit (other): x-ray

Release 10 — days 1–6 daily, dose 3

2021-10-04

Systemic reaction (other): dizzy. tight breathing.

2021-10-06

Systemic reaction (other): loss appetite

2021-10-07

Systemic reaction (other): loss of taste, loss of appetite

2021-10-08

Systemic reaction (other): loss of taste

Release 10 — day 42, dose 3

2021-11-14

Symptoms: increased pulse
Healthcare visit (other): holter monitor

Release 11 — 6 months, dose 3

2022-04-03

Symptoms: heart rythm/ SVT.

Release 12 — 12 months, dose 3

2022-10-03

Symptoms: Elevated Liver enzymes, high cholesterol, severe arthritis like pain in hands, fatigue.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event ✓ ✓ ✓
SDArrhythmia · · ✓
SDArthralgia ✓ ✓ ✓
SDBlood cholesterol increased · · ✓
SDFatigue · · ✓
SDHeart rate increased · · ✓
SDHepatic enzyme increased · · ✓
SDPain in extremity · · ✓
SDSupraventricular tachycardia · · ✓
SROAgeusia · · ✓
SROChest discomfort · · ✓
SRODecreased appetite · · ✓
SRODizziness · · ✓
SRODysphonia ✓ ✓ ✓
SROInjection site mass ✓ ✓ ✓
SROInjection site swelling ✓ ✓ ✓
SRORespiratory tract congestion ✓ ✓ ✓
SRORhinorrhoea ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release